Forcimet G 1 Tablet PR is a combination oral antidiabetic medication containing Glimepiride 1mg and Metformin 500mg, designed to improve glycemic control in patients with type 2 diabetes mellitus. Glimepiride, a sulfonylurea class drug, stimulates pancreatic beta cells to release insulin, thereby reducing blood glucose levels. Metformin, a biguanide, decreases hepatic glucose production and enhances peripheral glucose uptake and utilization, contributing to improved insulin sensitivity. The prolonged-release formulation ensures a steady release of the active ingredients, promoting better blood sugar regulation throughout the day and minimizing gastrointestinal side effects commonly associated with immediate-release metformin. Forcimet G 1 Tablet PR is typically prescribed when diet, exercise, and monotherapy with either agent alone have not achieved adequate glycemic control. It is important for patients to adhere to prescribed dosage and lifestyle modifications, including diet and physical activity, to maximize therapeutic benefits. Monitoring blood glucose levels regularly is essential to avoid hypoglycemia, a potential side effect due to glimepiride. This medication is contraindicated in patients with type 1 diabetes, diabetic ketoacidosis, severe renal or hepatic impairment, and should be used cautiously in those with cardiovascular conditions. Always consult a healthcare professional before starting or adjusting therapy with Forcimet G 1 Tablet PR.